GKIM
GW&K Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Buy |
1,682
+514
| +44% | +$23.8K | ﹤0.01% | 448 |
|
|
2025
Q1 | $71K | Sell |
1,168
-10
| -0.8% | -$608 | ﹤0.01% | 437 |
|
|
2024
Q4 | $67K | Buy |
1,178
+111
| +10% | +$6.31K | ﹤0.01% | 432 |
|
|
2024
Q3 | $55K | Buy |
1,067
+344
| +48% | +$17.7K | ﹤0.01% | 454 |
|
|
2024
Q2 | $30K | Sell |
723
-181
| -20% | -$7.51K | ﹤0.01% | 496 |
|
|
2024
Q1 | $49K | Buy |
904
+221
| +32% | +$12K | ﹤0.01% | 430 |
|
|
2023
Q4 | $35K | Sell |
683
-37
| -5% | -$1.9K | ﹤0.01% | 439 |
|
|
2023
Q3 | $42K | Buy |
720
+54
| +8% | +$3.15K | ﹤0.01% | 406 |
|
|
2023
Q2 | $43K | Buy |
+666
| New | +$43K | ﹤0.01% | 393 |
|
|
2022
Q3 | – | Sell |
-265
| Closed | -$20K | – | 453 |
|
|
2022
Q2 | $20K | Buy |
265
+109
| +70% | +$8.23K | ﹤0.01% | 415 |
|
|
2022
Q1 | $11K | Buy |
+156
| New | +$11K | ﹤0.01% | 427 |
|
|
2015
Q1 | – | Sell |
-176,054
| Closed | -$10.4M | – | 222 |
|
|
2014
Q4 | $10.4M | Buy |
176,054
+2,842
| +2% | +$168K | 0.25% | 131 |
|
|
2014
Q3 | $8.87M | Buy |
173,212
+5,811
| +3% | +$297K | 0.23% | 130 |
|
|
2014
Q2 | $8.12M | Sell |
167,401
-468
| -0.3% | -$22.7K | 0.21% | 137 |
|
|
2014
Q1 | $8.72M | Sell |
167,869
-117,097
| -41% | -$6.08M | 0.23% | 133 |
|
|
2013
Q4 | $15.1M | Sell |
284,966
-93,118
| -25% | -$4.95M | 0.41% | 96 |
|
|
2013
Q3 | $17.5M | Buy |
378,084
+20,248
| +6% | +$937K | 0.53% | 79 |
|
|
2013
Q2 | $16M | Buy |
+357,836
| New | +$16M | 0.59% | 79 |
|